BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3949275)

  • 1. [Vincamine in cerebrovascular insufficiency. Occupational medicine approaches in cerebral diseases].
    Steinhäuser B
    Fortschr Med; 1986 Jan; 104(1-2):23-6. PubMed ID: 3949275
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebral regulation-cerebral regulators.
    Braun P
    Ther Hung; 1980; 28(3):98-104. PubMed ID: 7221974
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P; Periti G; Colombo Pirola L
    Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of treatment with Vincimax in 60 cases of cerebral circulatory insufficiency].
    Desruelles J; Camart JF
    LARC Med; 1981 Dec; 1(3):86-90. PubMed ID: 7349693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].
    Ambrozi L; Bruck J; Tschabitscher H
    Nervenarzt; 1982 Mar; 53(3):141-3. PubMed ID: 7078689
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P
    Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vincamine in the therapy of cerebral vascular diseases in the aged].
    De Candia O; Bartolucci E; Mancinella A; Baghiris D
    Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
    [No Abstract]   [Full Text] [Related]  

  • 8. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
    Holemans P
    Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vincamine in cerebral arteriosclerosis: therapeutic effects evaluated clinically and by retinal fluoro-angiography].
    Ardito R
    Clin Ter; 1979 Mar; 88(5):461-12. PubMed ID: 466968
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with the combination of vincamine and papaverine in chronic brain syndrome].
    Cacciatori D
    Clin Ter; 1979 Jun; 89(5):473-82. PubMed ID: 535324
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the vincamine-papaverine association iii. clinical use in cardiac patients.
    Pirani R; Cattani L; Tomasi AM; Masoni A
    Agressologie; 1978; 19(3):221-5. PubMed ID: 736222
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
    Riccardi T; Passeri F; Locatelli F
    Minerva Med; 1978 Sep; 69(42):2873-8. PubMed ID: 358021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of Cetal retard in cerebral insufficiency in general practice].
    Bartels H
    Med Klin; 1979 Oct; Suppl():46-7. PubMed ID: 542167
    [No Abstract]   [Full Text] [Related]  

  • 14. [Open clinical trial with (-)eburnamonine in patients suffering from cerebral ischemia].
    Musch B; Nemni R; Giusti C; Mandelli A; Canal N
    G Clin Med; 1980 Jan; 61(1):62-73. PubMed ID: 7450346
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
    Petronio G; Scali G; Casa B; Nonis E
    Clin Ter; 1980 Aug; 94(4):427-44. PubMed ID: 6257445
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled clinical study on the activity of vincamine-teprosylate in the so-called aging brain syndrome].
    Passeri M; Cucinotta D; Mancini M; Bia A; Palummeri E
    G Clin Med; 1982; 63(11-12):874-87. PubMed ID: 7182206
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
    Schenker H
    Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cerebroxine and the treatment of sudden deafness. Apropos of 2 representative cases].
    Van Geert G; Hennebert D
    Brux Med; 1979; 59(11-12):515-23. PubMed ID: 534950
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG; Cahn J
    Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of chronic cerebrovascular arteriosclerotic insufficiency in a geriatric patient].
    Cucinotta D; Palummeri E; Carapezzi C; Cocchi C
    G Clin Med; 1979 Mar; 60(3):225-33. PubMed ID: 520728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.